Status:
TERMINATED
The RAPID COVID Study - Application of Point-of-Care COVID-19 Testing
Lead Sponsor:
Ottawa Heart Institute Research Corporation
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is being conducted to study the use and application of a point-of-care (POC) Covid-19 test developed by Spartan BioSciences and recently approved for clinical use by Health Canada.
Detailed Description
This RAPID COVID-19 study is a prospective, unblinded clinical trial. POC testing utilizing the Spartan Cube COVID-19 platform will be performed on a cohort of 2200 hospitalized patients who have been...
Eligibility Criteria
Inclusion
- participants \>/= 18 years of age
- patients for whom POC testing would change their course of treatment (in opinion of treatment team)
Exclusion
- patients in whom conventional COVID-19 testing would not have otherwise been performed
- patients in whom immediate COVID-19 testing would not alter short-term treatment
- patients who refuse consent
Key Trial Info
Start Date :
March 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2021
Estimated Enrollment :
89 Patients enrolled
Trial Details
Trial ID
NCT04767958
Start Date
March 19 2021
End Date
August 31 2021
Last Update
May 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Ottawa Heart Institute
Ottawa, Ontario, Canada, K1Y4W7